HOME2019-03-11T17:27:49+00:00

The PD-MitoQUANT Project

Today, more than one million people live with Parkinson’s in Europe and this number is forecast to double by 2030. New, more effective treatments are urgently needed – but researchers and companies developing new drugs need to know more about how mitochondrial dysfunction is involved in disease progression and better models are needed for drug discovery and development.

PD-MitoQUANT is an Innovative Medicines Initiative (IMI) project that brings together academic experts, SMEs, pharmaceutical companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA) and patient advocacy organisation Parkinson’s UK to:

  • improve our understanding of mitochondrial dysfunction in Parkinson’s,

  • identify and validate molecular drivers and mechanisms in Parkinson’s, and

  • discover innovative therapeutic targets that can be further progressed by the EFPIA partners in the future.

Latest News

PI Ronald Melki CNRS is co-organizing Jacques Monod Conference 2020 in Brittany

October 29th, 2019|

In October 2020, PD-MitoQUANT PI Dr Ronald Melki, CNRS is co-chairing the Jacques Monod conference which is themed: Protein phase transitions in ageing and age-related diseases: from atomic resolution to cellular solutions. Several PD-MitoQUANT PIs will present here. Where: Roscoff (Bretagne), France When: October 12-16, 2020 REGISTRATION REQUEST and ABSTRACT SUBMISSION [...]

PD-MitoQUANT presented at International Symposium on Neurodegenerative Diseases in Texas

October 29th, 2019|

  PD-MitoQUANT PI Dr Ronald Melki of the Centre National de la Recherche Scientifique, CNRS was an invited speaker at the International Symposium on Neurodegenerative Diseases organized by the University of Texas Southwestern O’Donnell Brain Institute in Dallas, Texas and the Texas Alzheimer’s Research and Care Consortium. The meeting took [...]

PI Olga Corti, ICM acknowledges PD-MitoQUANT at two conferences

September 25th, 2019|

Institut du Cerveau et de la Moelle Epinière (ICM) PI Dr Olga Corti presented her work and acknowledged PD-MitoQUANT at two recent conferences. The first conference presentation was on September 3, 2019, at the 23rd Biennial ESN meeting in Milan. Olga's talk was titled: “From dysfunction of PINK1/Parkin-mediated mitochondrial quality [...]

Read more